Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Q: What does CUSIP 152309100 represent in this 13F holders report?

CUSIP 152309100 is the security identifier for CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share used to aggregate holder disclosures.

Q: How many institutions held CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share in Q1 2025?

130 institutional investors reported CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 152309100

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Ordinary shares, nominal value 0.002 GBP per share
Shares outstanding: 145,993,531
Total 13F shares: 124,913,742
Share change: +481,479
Total reported value: $1,797,461,231
Put/Call ratio: 501%
Price per share: $14.38
Number of holders: 130
Value change: -$6,439,160
Number of buys: 73
Number of sells: 52

Quarterly Holders Quick Answers

What is CUSIP 152309100?
CUSIP 152309100 identifies CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) as of Q1 2025

As of 31 Mar 2025, Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 124,913,742 shares. The largest 10 holders included Medicxi Ventures Management (Jersey) Ltd, Index Venture Life Associates VI Ltd, GENERAL ATLANTIC, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, First Light Asset Management, LLC, FARALLON CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, and FMR LLC. This page lists 130 institutional shareholders reporting positions in this security for the Q1 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.